Corvus Pharmaceuticals Target Price

See how CRVS's target price trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Share Price

$14.83

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-04-17	Goldman Sachs	$40	169.7% upside
2026-01-29	Mizuho SecuritiesGraig Suvannavejh	$30	102.3% upside
2026-01-22	JefferiesRoger Song	$42	183.2% upside
2026-01-21	Oppenheimer	$32	115.8% upside
2026-01-20	Barclays	$28	88.8% upside
2026-01-20	Mizuho Securities	$20	34.9% upside
2026-01-20	H.C. WainwrightSean Lee	$27	82.1% upside
2025-10-29	Mizuho Securities	$13	12.3% downside
2025-10-13	Barclays	$16	7.9% upside
2025-05-20	Mizuho SecuritiesGraig Suvannavejh	$11	25.8% downside
2024-11-13	JefferiesRoger Song	$13	12.3% downside
2024-10-22	Mizuho SecuritiesGraig Suvannavejh	$12	19.1% downside
2023-08-18	OppenheimerJeff Jones	$7	52.8% downside

Corvus Pharmaceuticals (CRVS) FAQ

Stockcircle tracks target price for Corvus Pharmaceuticals (CRVS), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Corvus Pharmaceuticals's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main CRVS overview so you can move from this figure to the surrounding analysis quickly.